Overall survival of perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in locally advanced gastric or gastrooesophageal junction adenocarcinoma undergoing D2 gastrectomy: An updated analysis of RESOLVE trial

被引：10

作者：

Zhang, X. ^{[1
]}

Li, Z. ^{[2
]}

Liang, H. ^{[3
]}

Xue, Y. ^{[4
]}

Wang, Y. ^{[5
]}

Zhou, Z. ^{[6
]}

Yu, J. ^{[7
]}

Chen, L. ^{[8
]}

Du, Y. ^{[9
]}

Li, G. ^{[10
]}

Xiao, G. ^{[11
]}

Wu, D. ^{[12
]}

Zhou, Y. ^{[13
]}

Dang, C. ^{[14
]}

He, Y. ^{[15
]}

Zhang, Z. ^{[16
]}

Sun, Y. ^{[17
]}

Li, Y. ^{[18
]}

Shen, L. ^{[1
]}

Ji, J. ^{[2
]}

机构：

[1] Peking Univ Canc Hosp, Dept Gastrointestinal Oncol, Beijing Canc Hosp, Beijing, Peoples R China

[2] Peking Univ Canc Hosp, Gastrointestinal Canc Ctr, Beijing Canc Hosp, Beijing, Peoples R China

[3] Tianjin Med Univ Canc Inst & Hosp, Dept Surg, Tianjin, Peoples R China

[4] Harbin Med Univ, Dept Surg, Canc Hosp, Harbin, Peoples R China

[5] Fudan Univ, Dept Surg, Shanghai Canc Ctr, Shanghai, Peoples R China

[6] Sun Yat Sen Univ, Dept Surg, Canc Ctr, Guangzhou, Peoples R China

[7] Zhejiang Univ, Affiliated Hosp 1, Dept Surg, Sch Med, Hangzhou, Peoples R China

[8] Chinese Peoples Liberat Army Gen Hosp, Dept Surg, Mil Hosp 301, Beijing, Peoples R China

[9] Zhejiang Canc Hosp, Dept Surg, Hangzhou, Peoples R China

[10] East Theater Gen Hosp PLA, Dept Surg, Nanjing, Peoples R China

[11] Beijing Hosp, Dept Surg, Beijing, Peoples R China

[12] Zhejiang Univ, Dept Surg, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China

[13] Qingdao Univ, Dept Surg, Affiliated Hosp, Qingdao, Shandong, Peoples R China

[14] Xi An Jiao Tong Univ, Dept Surg, Affiliated Hosp 1, Xian, Peoples R China

[15] Sun Yat Sen Univ, Dept Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[16] Capital Med Univ, Beijing Friendship Hosp, Dept Surg, Beijing, Peoples R China

[17] Fudan Univ, Dept Surg, Zhongshan Hosp, Shanghai, Peoples R China

[18] Hebei Med Univ, Dept Surg, Hosp 4, Shijiazhuang, Hebei, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.079

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA78

引用

页码：S1318 / S1319

页数：2

共 50 条

[21] Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
Zhichao Jiang
Yibin Xie
Wen Zhang
Chunxia Du
Yuxin Zhong
Yuelu Zhu
Liming Jiang
Lizhou Dou
Kang Shao
Yongkun Sun
Qi Xue
Yantao Tian
Shugeng Gao
Dongbing Zhao
Aiping Zhou
Gastric Cancer, 2024, 27 : 571 - 579
[22] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
Shitara, Kohei
Chin, Keisho
Yoshikawa, Takaki
Katai, Hitoshi
Terashima, Masanori
Ito, Seiji
Hirao, Motohiro
Yoshida, Kazuhiro
Oki, Eiji
Sasako, Mitsuru
Emi, Yasunori
Tsujinaka, Toshimasa
GASTRIC CANCER, 2017, 20 (01) : 175 - 181
[23] Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Bang, Yung-Jue
Kim, Young-Woo
Yang, Han-Kwang
Chung, Hyun Cheol
Park, Young-Kyu
Lee, Kyung Hee
Lee, Keun-Wook
Kim, Yong Ho
Noh, Sang-Ik
Cho, Jae Yong
Mok, Young Jae
Kim, Yeul Hong
Ji, Jiafu
Yeh, Ta-Sen
Button, Peter
Sirzen, Florin
Noh, Sung Hoon
LANCET, 2012, 379 (9813): : 315 - 321
[24] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
Kohei Shitara
Keisho Chin
Takaki Yoshikawa
Hitoshi Katai
Masanori Terashima
Seiji Ito
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Toshimasa Tsujinaka
Gastric Cancer, 2017, 20 : 175 - 181
[25] Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
Jiang, Zhichao
Xie, Yibin
Zhang, Wen
Du, Chunxia
Zhong, Yuxin
Zhu, Yuelu
Jiang, Liming
Dou, Lizhou
Shao, Kang
Sun, Yongkun
Xue, Qi
Tian, Yantao
Gao, Shugeng
Zhao, Dongbing
Zhou, Aiping
GASTRIC CANCER, 2024, 27 (03) : 571 - 579
[26] Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
Ren, Deng-Feng
Zheng, Fang-Chao
Zhao, Jun-Hui
Shen, Guo-Shuang
Ahmad, Raees
Zhang, Shui-Sheng
Zhang, Yu
Kan, Jie
Dong, Li
Wang, Zi-Yi
Zhao, Fu-Xing
Zhao, Jiu-Da
WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (10) : 373 - 383
[27] Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma
Zheng, Yanan
Wang, Zhenqiang
Yan, Chao
Yan, Min
Hou, Zhiguo
Zheng, Rongrong
Zhu, Zhenggang
Li, Chen
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
[28] Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
Deng-Feng Ren
Fang-Chao Zheng
Jun-Hui Zhao
Guo-Shuang Shen
Raees Ahmad
Shui-Sheng Zhang
Yu Zhang
Jie Kan
Li Dong
Zi-Yi Wang
Fu-Xing Zhao
Jiu-Da Zhao
World Journal of Clinical Cases, 2018, (10) : 373 - 383
[29] Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial).
Tokunaga, Masanori
Mizusawa, Junki
Machida, Nozomu
Fukagawa, Takeo
Katai, Hitoshi
Nishida, Yasunori
Yabusaki, Hiroshi
Ito, Seiji
Sano, Takeshi
Sasako, Mitsuru
Boku, Narikazu
Yoshikawa, Takaki
Katayama, Hiroshi
Haruhiko
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[30] A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
Park, S. H.
Lim, D. H.
Sohn, T. S.
Lee, J.
Zang, D. Y.
Kim, S. T.
Kang, J. H.
Oh, S. Y.
Hwang, I. G.
Ji, J. H.
Shin, D. B.
Yu, J., I
Kim, K-M
An, J. Y.
Choi, M. G.
Lee, J. H.
Kim, S.
Hong, J. Y.
Park, J. O.
Park, Y. S.
Lim, H. Y.
Bae, J. M.
Kang, W. K.
ANNALS OF ONCOLOGY, 2021, 32 (03) : 368 - 374

← 1 2 3 4 5 →